desloratadine

histamine receptor H1 ; Homo sapiens







20 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31406237 Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria. 2020 Feb 4
2 32406319 Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer. 2020 Jan-Dec 1
3 30863716 Quantum chemical calculation and binding modes of H1R; a combined study of molecular docking and DFT for suggesting therapeutically potent H1R antagonist. 2019 1
4 31274307 Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to Rupatadine. 2019 Jul 25 4
5 19236123 Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England. 2009 1
6 17298105 Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. 2007 1
7 17577463 Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial. 2007 Mar 1
8 17906161 Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment. 2007 Oct 1
9 16970513 Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. 2006 1
10 16259582 Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders. 2005 Nov 1
11 17523764 Predicting and establishing the clinical efficacy of a histamine h(1)-receptor antagonist : desloratadine, the model paradigm. 2005 1
12 15168099 Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. 2004 Jul 1
13 15564772 Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor. 2004 Dec 2
14 12962522 Desloratadine: an update of its efficacy in the management of allergic disorders. 2003 1
15 12167464 Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. 2002 Aug 9 6
16 12492724 Therapeutic points of intervention and clinical implications: role of desloratadine. 2002 1
17 12492727 Advances in allergy management. 2002 2
18 11243501 Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. 2001 2
19 12768222 Desloratadine: A preclinical and clinical overview. 2001 Apr 1
20 11080746 Therapeutic options in allergic disease: antihistamines as systemic antiallergic agents. 2000 Nov 1